Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 13
1965 33
1966 20
1967 28
1968 37
1969 29
1970 30
1971 15
1972 23
1973 56
1974 43
1975 72
1976 82
1977 80
1978 113
1979 126
1980 173
1981 155
1982 214
1983 215
1984 260
1985 244
1986 264
1987 241
1988 214
1989 231
1990 227
1991 229
1992 207
1993 227
1994 189
1995 160
1996 166
1997 141
1998 111
1999 125
2000 114
2001 104
2002 125
2003 100
2004 96
2005 136
2006 118
2007 106
2008 110
2009 115
2010 132
2011 106
2012 133
2013 148
2014 149
2015 135
2016 100
2017 119
2018 107
2019 130
2020 147
2021 164
2022 112
2023 120
2024 64

Text availability

Article attribute

Article type

Publication date

Search Results

7,465 results

Results by year

Filters applied: . Clear all
Page 1
Intranasal metoclopramide.
Ormrod D, Goa KL. Ormrod D, et al. Drugs. 1999 Aug;58(2):315-22; discussion 323-4. doi: 10.2165/00003495-199958020-00012. Drugs. 1999. PMID: 10473023 Review.
Intranasal metoclopramide is a new formulation of an established and effective antiemetic drug. ...One 30 patient study suggests that intranasal metoclopramide has similar efficacy to oral metoclopramide in the treatment of functional dyspepsia. ...
Intranasal metoclopramide is a new formulation of an established and effective antiemetic drug. ...One 30 patient study suggests that …
Metoclopramide.
Burrows CF. Burrows CF. J Am Vet Med Assoc. 1983 Dec 1;183(11):1341-3. J Am Vet Med Assoc. 1983. PMID: 6643268 No abstract available.
Beyond Metoclopramide for Gastroparesis.
Camilleri M. Camilleri M. Clin Gastroenterol Hepatol. 2022 Jan;20(1):19-24. doi: 10.1016/j.cgh.2021.08.052. Epub 2021 Sep 20. Clin Gastroenterol Hepatol. 2022. PMID: 34547280 Free PMC article. No abstract available.
Metoclopramide for the treatment of diabetic gastroparesis.
Shakhatreh M, Jehangir A, Malik Z, Parkman HP. Shakhatreh M, et al. Expert Rev Gastroenterol Hepatol. 2019 Aug;13(8):711-721. doi: 10.1080/17474124.2019.1645594. Epub 2019 Jul 30. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31314613 Review.
The aim of this article is to provide a concise review of the pharmacology, clinical efficacy and tolerability of metoclopramide. Areas covered: We searched PubMed using the key words 'metoclopramide', 'diabetic gastroparesis', and 'gastric emptying'. ...Expert opin …
The aim of this article is to provide a concise review of the pharmacology, clinical efficacy and tolerability of metoclopramide. Are …
Metoclopramide--a review.
Desmond PV, Watson KJ. Desmond PV, et al. Med J Aust. 1986 Mar 31;144(7):366-9. doi: 10.5694/j.1326-5377.1986.tb115923.x. Med J Aust. 1986. PMID: 3515136 Review.
Metoclopramide has wide applications in both clinical and experimental medicine. ...It is being used increasingly in the management of nausea and vomiting, and at high doses will significantly relieve the emesis that is induced by cytotoxic agents. Metoclopramide al
Metoclopramide has wide applications in both clinical and experimental medicine. ...It is being used increasingly in the management o
Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited.
Al-Saffar A, Lennernäs H, Hellström PM. Al-Saffar A, et al. Neurogastroenterol Motil. 2019 Nov;31(11):e13617. doi: 10.1111/nmo.13617. Epub 2019 May 2. Neurogastroenterol Motil. 2019. PMID: 31050085 Review.
The aim of our study was to review mechanism(s) of action and pharmacokinetic-pharmacodynamic properties of metoclopramide, as well as the risk of metoclopramide-induced tardive dyskinesia, factors that may change drug exposure in humans, and to summarize the clinic …
The aim of our study was to review mechanism(s) of action and pharmacokinetic-pharmacodynamic properties of metoclopramide, as well a …
Metoclopramide.
Brady K. Brady K. Med J Aust. 1986 Sep 1;145(5):243-4. doi: 10.5694/j.1326-5377.1986.tb113827.x. Med J Aust. 1986. PMID: 3747906 No abstract available.
Metoclopramide.
[No authors listed] [No authors listed] N Engl J Med. 1981 Oct 29;305(18):1093. doi: 10.1056/NEJM198110293051818. N Engl J Med. 1981. PMID: 7278928 No abstract available.
Pharmacologic treatment of gastroparesis: What is (still) on the horizon?
Schweckendiek D, Pohl D. Schweckendiek D, et al. Curr Opin Pharmacol. 2023 Oct;72:102395. doi: 10.1016/j.coph.2023.102395. Epub 2023 Aug 26. Curr Opin Pharmacol. 2023. PMID: 37639905 Free article. Review.
Treatment strategies include nutritional support, pharmacologic agents or surgery for refractory cases. Metoclopramide is the first and only FDA approved pharmacologic agent for (diabetic) Gastroparesis. ...
Treatment strategies include nutritional support, pharmacologic agents or surgery for refractory cases. Metoclopramide is the first a …
Metoclopramide-induced akathisia.
Hamilton FA. Hamilton FA. Mil Med. 1987 Nov;152(11):585-6. Mil Med. 1987. PMID: 3122084 No abstract available.
7,465 results